SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-003085
Filing Date
2024-01-10
Accepted
2024-01-10 20:26:46
Documents
1
Period of Report
2024-01-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm242561-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm242561-1_3seq1.xml 3 7803
  Complete submission text file 0001104659-24-003085.txt   9437
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Issuer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address
Ronsheim Matthew (Reporting) CIK: 0001824386 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30319 | Film No.: 24527772